Health care stocks were edging higher pre-bell Friday as the Health Care Select Sector SPDR Fund (XLV) was slightly advancing and the iShares Biotechnology ETF (IBB) was up 0.4% recently.
Viatris (VTRS) shares were down more than 3% after the company said a phase 3 study evaluating the efficacy and safety of MR-139 ophthalmic ointment in subjects with blepharitis did not meet its primary endpoint of complete resolution of debris after six weeks of twice daily dosing.
Telomir Pharmaceuticals (TELO) shares were up more than 153% after the company said its lead candidate Telomir-1 may help restore a tumor suppressor in human prostate cancer cells.
Sarepta Therapeutics (SRPT) shares were down 25% following reports of another patient death in the company's gene therapy trial.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。